![Marc Chamberlain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Marc Chamberlain currently works at Lantern Pharma, Inc., as Chief Medical Officer-Starlight Therapeutics from 2023.
Dr. Chamberlain also formerly worked at Seagen, Inc., as Medical Director, Cascadian Therapeutics LLC, as Medical Director, Angiochem, Inc., as Medical Director, and Pionyr Immunotherapeutics, Inc., as Medical Director.
Cargos activos de Marc Chamberlain
| Empresas | Cargo | Inicio |
|---|---|---|
| LANTERN PHARMA INC. | Corporate Officer/Principal | 01/11/2023 |
Antiguos cargos conocidos de Marc Chamberlain.
| Empresas | Cargo | Fin |
|---|---|---|
Angiochem, Inc.
 Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for brain diseases | Corporate Officer/Principal | - |
| SEAGEN INC. | Corporate Officer/Principal | - |
Pionyr Immunotherapeutics, Inc.
 Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-based Immuno-oncology therapeutics | Corporate Officer/Principal | - |
| CASCADIAN THERAPEUTICS INC (USA) | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
9
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for brain diseases | Health Technology |
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-based Immuno-oncology therapeutics | Health Technology |
Lantern Pharma, Inc.
 Lantern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drug from advanced genomics and artificial intelligence | Health Technology |
- Bolsa de valores
- Insiders
- Marc Chamberlain
